Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.57
Delayed Data
As of 4:01pm ET
 -0.005 / -0.87%
Today’s Change
0.33
Today|||52-Week Range
2.12
-62.00%
Year-to-Date

Today’s Trading

Previous close0.57
Today’s open0.60
Day’s range0.52 - 0.60
Volume71,293
Average volume (3 months)128,481
Market cap$28.2M
Dividend yield--
Data as of 4:01pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-100.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+25.10%
P/E ratioNM
Price/Sales46.76
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
XBIOXenetic Biosciences ...+0.08+2.44%
NVGNNovogen Ltd0.000.00%
OREXOrexigen Therapeutic...0.000.00%
HTBXHeat Biologics Inc-0.13-10.48%
Data as of 3:59pm ET, 12/05/2016

Financials

Last reporting dateOctober 28, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$1.2M
Annual profit (last year)-$11.7M
Net profit margin-996.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alan F. Joslyn
Chief Financial Officer, Secretary &
Treasurer
Michael O'Keefe Sullivan
Corporate headquarters
Tampa, Florida

Forecasts


Search for Jobs